Achillion Pharmaceuticals Inc - Company & Market Research Reports

Achillion Pharmaceuticals is a biopharmaceutical company that develops small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. Its drug candidates for treating chronic hepatitis C virus (HCV) infection comprise Odalasvir, ACH-3422 and Sovaprevir. Achillion has a proprietary library of over 1,300 potent and specific complement inhibitors. The company was founded in 1998 and is headquartered in New Haven, Connecticut.

From
From
From
From
Hepatitis C - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatitis C - Pipeline Review, H1 2018

  • Drug Pipelines
  • 431 Pages
From
From
From
From
From
From
Glomerulonephritis - Pipeline Review, H2 2018 - Product Thumbnail Image

Glomerulonephritis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 212 Pages
From
Glomerulonephritis - Pipeline Review, H1 2018 - Product Thumbnail Image

Glomerulonephritis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 201 Pages
From
From
From
From
Loading Indicator
adroll